ASX:CTE Cryosite (CTE) Stock Price, News & Analysis Add Compare Share Share Stock Analysis Stock AnalysisBuy This Stock About Cryosite Stock (ASX:CTE) 30 days 90 days 365 days Advanced Chart Get Cryosite alerts:Sign Up Key Stats Today's Range N/A50-Day Range N/A52-Week Range N/AVolume418 shsAverage VolumeN/AMarket CapitalizationA$36.36 millionP/E Ratio19.76Dividend Yield9.40%Price TargetN/AConsensus RatingN/A Company Overview Cryosite Limited offers outsourced clinical trials logistic services in Australia. It operates through two segments, Clinical Trials and Biological Services Logistics, and Cord Blood and Tissues Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological, as well as logistics services to the clinical trials, research, and pharmaceutical industries. The Cord Blood and Tissues Storage segment offers long term storage solutions for cord blood and tissue samples. It serves research, medical, pharmaceutical, and biotechnology industries. The company was incorporated in 1999 and is based in South Granville, Australia. Read More Receive CTE Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Cryosite and its competitors with MarketBeat's FREE daily newsletter. Email Address CTE Stock News HeadlinesCryosite (ASX:CTE) Ticks All The Boxes When It Comes To Earnings GrowthApril 21, 2025 | finance.yahoo.comCryosite Limited Announces Director’s Share AcquisitionApril 9, 2025 | tipranks.com$100 Trillion “AI Metal” Found in American Ghost TownJeff Brown recently traveled to a ghost town in the middle of an American desert… To investigate what could be the biggest technology story of this decade. In short, he believes what he's holding in his hand is the key to the $100 trillion AI boom… And only one company here in the U.S. can mine this obscure metal.July 7 at 2:00 AM | Brownstone Research (Ad)Cryosite Limited Issues Unquoted Equity Securities for Employee IncentiveMarch 16, 2025 | tipranks.comWith EPS Growth And More, Cryosite (ASX:CTE) Makes An Interesting CaseNovember 13, 2024 | finance.yahoo.comCryosite Limited Announces 2024 Annual General MeetingOctober 21, 2024 | markets.businessinsider.comCryosite (ASX:CTE) Will Pay A Dividend Of A$0.02August 22, 2024 | finance.yahoo.comHere's Why Cryosite (ASX:CTE) Has Caught The Eye Of InvestorsMarch 21, 2024 | finance.yahoo.comSee More Headlines Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Diagnostics & Research Sub-IndustryN/A Current SymbolASX:CTE CIKN/A Webwww.cryosite.com Phone61 2 8865 2000FaxN/AEmployees25Year FoundedN/AProfitability EPS (Trailing Twelve Months)A$0.04 Trailing P/E Ratio19.76 Forward P/E RatioN/A P/E GrowthN/ANet IncomeA$1.84 million Net Margins14.59% Pretax MarginN/A Return on Equity84.70% Return on Assets6.06% Debt Debt-to-Equity Ratio168.74 Current Ratio1.94 Quick Ratio1.76 Sales & Book Value Annual SalesA$12.61 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow0.55 Book ValueA$0.03 per share Price / BookN/AMiscellaneous Outstanding Shares48,810,000Free FloatN/AMarket CapA$36.36 million OptionableNot Optionable Beta0.40 20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free Report This page (ASX:CTE) was last updated on 7/7/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cryosite Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Cryosite With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.